Insulin-like Growth Factor-1 (IGF-1)-derived Peptide Protects against Diabetes in NOD Mice
Authors:
- 1 September 2004
- journal article
- research article
- Published by Taylor & Francis in Autoimmunity
- Vol. 37 (6-7) , 481-487
Abstract
Spontaneous diabetes in non-obese diabetic (NOD) mice results from β-cell destruction by autoreactive T lymphocytes. Here, we report the significance of insulin-like growth factor-1 (IGF-1) peptide as a tool for the prevention of type 1 diabetes. Female NOD mice were immunized with a subcutaneous injection of IGF-1, glutamic acid decarboxylase (GAD), insulin or IGF-1-derived peptides (residues 8-23, 24-41 or 50-70) in incomplete Freund's adjuvant (IFA) or with IFA only as the control group at 4 weeks of age, and observed up to 36–37 weeks of age. Diabetes onset was significantly suppressed and delayed in the IGF-1 group as compared to the GAD, insulin and control groups (pp<0.02). Although the degree of insulitis in all treated mice was not significantly different, a significant number of IL-4-producing cells in response to IGF-1 peptides were detected in (50-70)IGF-1-treated mice in intracellular cytokine assay. In conclusion, IGF-1 peptide 50-70 immunizations of NOD mice suppressed and delayed diabetes onset, probably through amplification of the Th2-type response. It was suggested that IGF-1 peptide 50-70 immunization can be used as a tool for prevention of type 1 diabetes.Keywords
This publication has 15 references indexed in Scilit:
- Protection from Insulin Dependent Diabetes Mellitus Afforded by Insulin Antigens in Incomplete Freund's Adjuvant Depends on Route of AdministrationJournal of Autoimmunity, 1998
- Insulin-like growth factor I (IGF-I) delays the onset of diabetes in non-obese diabetic (NOD) miceDiabetes Research and Clinical Practice, 1996
- Antigen Based Therapies to Prevent Diabetes in NOD MiceJournal of Autoimmunity, 1996
- Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23).Proceedings of the National Academy of Sciences, 1996
- Peptide therapy for diabetes in NOD miceThe Lancet, 1994
- Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic miceNature, 1993
- Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin.Proceedings of the National Academy of Sciences, 1991
- Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65-kDa heat shock protein.Proceedings of the National Academy of Sciences, 1991
- Induction and therapy of autoimmune diabetes in the non-obese diabetic (NOD/Lt) mouse by a 65-kDa heat shock protein.Proceedings of the National Academy of Sciences, 1990
- Cell-mediated cytotoxic islet cell surface antibodies to human pancreatic beta cellsDiabetologia, 1984